
Investment Focus
Life Sciences
Engineered Biology
Companies
Infinimmune
Ben Kim is a Partner at Playground Global where he helps identify the founders and companies that are revolutionizing engineered biology. At Playground, he has sourced and led investments into companies including Atomic AI, Infinimmune, Insamo, Outpace Bio, Manifold Bio and Lassogen.
Prior to Playground, Ben was a PhD graduate student and an NSF Fellow at Stanford University, where he studied Bioengineering and Biomedical Engineering.